UPDATE: Cantor Fitzgerald Starts Affimed Therapeutics (AFMD) at Overweight
Tweet Send to a Friend
(Updated - February 23, 2022 6:36 AM EST)
Cantor Fitzgerald analyst Li Watsek initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Li Watsek initiates coverage on Affimed Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
